Together, these data indicate that ID3 deficiency in KCs impairs their activation by tumour cells, possibly through dysregulating expression by KCs of macrophage inhibitory and activating receptors, resulting in impaired phagocytosis of tumour cells, and decreased recruitment and non-cognate activation of effector CD8+ T cells and NK cells. The gene discussed is CD8A; the disease is neoplasm.